Igrene (ABI) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Net loss for the quarter was 1,069 KSEK, compared to a loss of 517 KSEK in the same quarter last year.
For the nine-month period, net loss was 2,407 KSEK, improving from a loss of 2,752 KSEK year-over-year.
Strategic focus remains on extracting carbon and hydrogen from methane deposits in Siljansringen, with new technology partnerships to enable emission-free production.
Financial highlights
Quarterly revenue was 0 KSEK; nine-month revenue was 155 KSEK, mainly from asset sales.
Operating expenses for the quarter totaled 1,069 KSEK, up from 517 KSEK year-over-year.
Cash and cash equivalents at period end were 2,072 KSEK, down from 4,617 KSEK a year earlier.
Equity at period end was 21,798 KSEK, with a solid equity ratio of 85.0%.
Outlook and guidance
Management expects regulatory changes may allow for natural gas extraction, given political shifts and EU classification of natural gas as green energy.
Partnership with SEID AS aims to demonstrate commercial viability of hydrogen and carbon production, with plans for a pilot plant.
Latest events from Igrene
- Losses narrowed, liquidity improved, and strategic focus is on renewable methane conversion.ABI
Q1 202616 Jan 2026 - Wider losses and zero revenue, but strengthened equity after rights issue; regulatory hurdles persist.ABI
Q4 202517 Oct 2025 - Regulatory setbacks halted project progress despite strong liquidity and high equity ratio.ABI
Q3 202518 Jul 2025 - Net loss increased, no dividend, and focus shifts to emission-free hydrogen and carbon projects.ABI
Q4 202413 Jun 2025 - Losses increased and demo plant delayed, but equity and cash position strengthened.ABI
Q2 20256 Jun 2025 - Losses increased but cash strengthened after rights issue; focus on green hydrogen tech.ABI
Q1 20256 Jun 2025